UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$230,459
+74.3%
27,081
+109.3%
0.00%
Q1 2024$132,247
+86.5%
12,9400.0%0.00%
Q4 2023$70,911
+45.0%
12,9400.0%0.00%
Q3 2023$48,913
-100.0%
12,940
-77.5%
0.00%
-100.0%
Q4 2020$2,668,026,00057,5750.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$34,149,80510.69%
K2 PRINCIPAL FUND, L.P. 2,461,672$20,948,8293.90%
Nextech Invest Ltd. 1,910,029$16,254,3472.73%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$94,273,1591.57%
Orbimed Advisors 9,240,887$78,639,9481.55%
RA Capital Management 10,860,977$92,426,9141.22%
SECTORAL ASSET MANAGEMENT INC 236,937$2,016,3340.82%
Sio Capital Management, LLC 217,864$1,854,0230.50%
DAFNA Capital Management LLC 239,194$2,035,5410.49%
ClariVest Asset Management LLC 287,596$2,447,4420.25%
View complete list of SILVERBACK THERAPEUTICS INC shareholders